Navigation Links
Wes Wheeler Appointed as CEO by Marken's Board of Directors
Date:5/25/2011

LONDON, May 25, 2011 /PRNewswire/ -- The Marken Board of Directors is pleased to announce the appointment of Wesley P. Wheeler, MBA as Chief Executive Officer. Mr. Wheeler succeeds Gerard Barba, who will remain the Chairman of the Marken Board of Directors.

Marken's Board and executive management team have sought to add an executive such as Mr. Wheeler for his in depth of experience in the life science industry as well as a strong background in logistics to further strengthen market leadership and maintain Marken's solid growth path.

Prior to joining Marken, Wes held the title of President and CEO of Patheon Inc., a top contract manufacturing services company. Wes was also a former President of Valeant Pharmaceuticals International, and has previously held senior executive roles of increasing responsibility in manufacturing, marketing and engineering at GlaxoSmithKline, plc. Preceding his 22 year career in pharmaceuticals, Mr. Wheeler had a successful 12 year career at ExxonMobil. He holds a bachelor's degree in Mechanical Engineering and a Masters of Business Administration.

"As the nature of biopharmaceutical R&D changes, well controlled clinical supply chains will be a significant factor in the success of key life science companies and the industries that support them. The Board and I feel that Wes can bring his experience from the drug manufacturing, biotechnology and traditional pharmaceutical industries to augment an already strong management team and continue Marken's growth," said Gerard Barba, Marken's Chairman.

Mr. Khawar Mann, managing partner, APAX LLP., said: "We are delighted that Wes has agreed to join us at Marken. His operations background and successful track record in the pharmaceutical industry will give us the tools we need to continue building Marken's portfolio of services and geographies, and thus realize our greatest potential as a leading logistics services provider."

About Marken

Founded in
'/>"/>

SOURCE Marken
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc.
2. GRAPHENE-CA appointed an EU Future Emerging Technology flagship pilot
3. David P. Lang Appointed Vice President of CryoLife International, Inc.
4. Olivier BOHUON appointed Chief Executive Officer of Pierre Fabre SA
5. Torbjorn Bjerke Appointed as new CEO for Karolinska Development
6. Shawn Cross Appointed CEO of Burrill Merchant Banking Group
7. New President and CEO appointed at Ocean Nutrition Canada Limited
8. Professor Sander van Deventer Appointed to Supervisory Board of AMT
9. New Board Director Appointed
10. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
11. Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
(Date:1/14/2014)... Jan. 14, 2014 As pet owners drew up their lists ... them wrote: "Take better care of my furry companion." Nowadays there ... and top-brand carrying cases to take the little canine or feline ... feel compelled to buy some pricey toys at the pet store. ...
(Date:1/14/2014)... In recent years, growing suspicion about the pharmaceutical ... and promotion has led to unprecedented levels of public ... about the insidious impact of commercialization of research, has ... the world’s biggest pharmas for illegal marketing activities, allegations ...
(Date:1/14/2014)... 2014 Kerr Corporation, a leading manufacturer of ... how-to information about dual arch impressions on its dental blog. ... Impressions,” the blog entry serves up a list of tips ... step-by-step demonstration by Dr. David Little as he crafts a ...
Breaking Biology Technology:TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3
... This release is available in German . ... from the physics department at the TUM discovered an entirely ... grid of magnetic eddies. Together with the team of Professor ... properties of these eddies, so-called skyrmions, named after the British ...
... Calif., Feb. 21, 2012 Onyx Pharmaceuticals, Inc. (Nasdaq: ... conferences in February and March. 2012 Citi Global ... Healthcare Conference on Monday, February 27, 2012 at 10:00 a.m. Eastern ... Company 32nd Annual Health Care Conference Onyx will present at ...
... 21, 2012  Wake Forest Baptist Medical Center has ... a new state-of-the-art, world-class 242,000 square foot biotechnology ... growth of Wake Forest Baptist,s many renowned research ... companies generated by researchers, discoveries and space for ...
Cached Biology Technology:Saving data in vortex structures 2Onyx Pharmaceuticals to Present at Upcoming Investor Conferences 2Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 2Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 3Wake Forest Baptist Medical Center Unveils Historic World-Class Biotech Research & Innovation Center in Downtown Winston-Salem's Growing Piedmont Triad Research Park 4
(Date:4/23/2014)... domestic heating may contribute to early fetal death according ... Research Institute of Children,s Hospital Los Angeles and Ulaanbaatar, ... , In a paper published today in the journal ... strong statistical correlations" between seasonal ambient air pollutants and ... has one of the highest levels of air pollution ...
(Date:4/23/2014)... hungry diner ripping open a dinner roll, a fuel ... open a hydrogen molecule. Now researchers have captured a ... halves of its hydrogen feast. The view confirms previous ... catalyst work better for alternative energy uses. , This ... where the hydrogen halves end up in the structure ...
(Date:4/23/2014)... shows that male black widow spiders prefer their female ... of mate preference by male spiders. , ... Maydianne Andrade, a professor in UTSC,s Department of Biological ... wild that males overwhelmingly chose to mate with well-fed, ... tell whether a potential mate is well-fed and unmated ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Picky male black widow spiders prefer well-fed virgins 2
... research team has tested the utility of the short version ... disability in patients with depression, "which in the case of ... of the instrument." In Spain, more than 10% of ... is usually the first to screen an individual who feels ...
... today by ESA,s Envisat satellite, shows the vast cloud of ... Iceland, more than 1000 km away. Carried by winds ... the eruption of the Eyjafjallajoekull glacier in southwest Iceland has ... Scandinavia, with further disruption in northern Europe expected later today. ...
... This press release is available in French . ... of the 20th century, but new research shows initiatives of ... dollars as people might think. McGill University Biologist Dr. Jonathan ... most affected by them is a far more effective and ...
Cached Biology News:It takes only 5 minutes to assess disability in patients with depression 2Trying to eradicate a disease is a waste of money: researcher 2